検索結果 - Jon Chung

結果の絞り込み
  1. 1
    Cdk2 Is Required for p53-Independent G2/M Checkpoint Control

    Cdk2 Is Required for p53-Independent G2/M Checkpoint Control 著者: Jon Chung, Fred Bunz

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor

    Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor 著者: Andrew R. Larsen, Ren-Yuan Bai, Jon Chung, Alexandra Borodovsky, Charles M. Rudin, Gregory J. Riggins, Fred Bunz

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Pan-Cancer Analysis of <i>CDK12</i> Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype

    Pan-Cancer Analysis of <i>CDK12</i> Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype 著者: Ethan Sokol, Dean C. Pavlick, Garrett M. Frampton, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali, Tamara L. Lotan, Drew M. Pardoll, Jon Chung, Emmanuel S. Antonarakis

    出版事項 2019
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma

    Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma 著者: Andrea Necchi, Russell W. Madison, Sumanta K. Pal, Jeffrey S. Ross, Neeraj Agarwal, Guru Sonpavde, Monika Joshi, Ming Yin, Vincent A. Miller, Petros Grivas, Jon Chung, Siraj M. Ali

    出版事項 2020
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Identification of Targetable <i>ALK</i> Rearrangements in Pancreatic Ductal Adenocarcinoma

    Identification of Targetable <i>ALK</i> Rearrangements in Pancreatic Ductal Adenocarcinoma 著者: Aatur D. Singhi, Siraj M. Ali, Jill Lacy, Andrew Hendifar, Khanh Nguyen, Jamie Koo, Jon Chung, Joel Greenbowe, Jeffrey S. Ross, Marina N. Nikiforova, Herbert J. Zeh, Inderpal S. Sarkaria, Anil K. Dasyam, Nathan Bahary

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy

    Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy 著者: Hyunseok Kang, Dean Pettinga, Adrian D. Schubert, Paul W. Ladenson, Douglas W. Ball, Jon Chung, Alexa B. Schrock, Russell W. Madison, Garrett M. Frampton, Phil Stephens, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Pan-Cancer Analysis of <i>BRCA1</i> and <i>BRCA2</i> Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity

    Pan-Cancer Analysis of <i>BRCA1</i> and <i>BRCA2</i> Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity 著者: Ethan S. Sokol, Dean C. Pavlick, Hossein Khiabanian, Garrett M. Frampton, Jeffrey S. Ross, Jeffrey P. Gregg, Primo N. Lara, Steffi Oesterreich, Neeraj Agarwal, Andrea Necchi, Vincent A. Miller, Brian M. Alexander, Siraj M. Ali, Shridar Ganesan, Jon Chung

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer

    Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non–Small Cell Lung Cancer 著者: Alexa B. Schrock, Allison W. Welsh, Jon Chung, Dean C. Pavlick, Eric Bernicker, Ben Creelan, Brady Forcier, Jeffrey S. Ross, Philip J. Stephens, Siraj M. Ali, Ibiayi Dagogo‐Jack, Alice T. Shaw, Tianhong Li, Sai‐Hong Ignatius Ou, Vincent A. Miller

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer

    Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer 著者: Ethan Sokol, Yongzhi Feng, Dexter X. Jin, Ahmed Basudan, A.V. Lee, Jennifer M. Atkinson, Jun‐Jiang Chen, Philip J. Stephens, Garrett M. Frampton, Piyush B. Gupta, Jeffrey S. Ross, Jon Chung, Steffi Oesterreich, Siraj M. Ali, Ryan J. Hartmaier

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    HER2 V659 and G660 transmembrane mutations that stabilize homo- and hetero-dimerization are rare oncogenic drivers in lung adenocarcinoma that are clinically responsive to afatinib

    HER2 V659 and G660 transmembrane mutations that stabilize homo- and hetero-dimerization are rare oncogenic drivers in lung adenocarcinoma that are clinically responsive to afatinib 著者: S.-H.I. Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Charbel Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, J.S. Ross, P. Stephens, V.A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers

    Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers 著者: Aatur D. Singhi, Ben George, Joel Greenbowe, Jon Chung, James Suh, Anirban Maitra, Samuel J. Klempner, Andrew Hendifar, Javle Milind, Talia Golan, Randall E. Brand, Amer H. Zureikat, Somak Roy, Alexa B. Schrock, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali, Nathan Bahary

    出版事項 2019
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib

    HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib 著者: Sai‐Hong Ignatius Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Carolina Kawamura Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors

    Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors 著者: Jon Chung, Ninad Dewal, Ethan Sokol, Paul Mathew, Robert P. Whitehead, Sherri Z. Millis, Garrett M. Frampton, Gennady Bratslavsky, Sumanta K. Pal, Richard J. Lee, Andrea Necchi, Jeffrey P. Gregg, Primo N. Lara, Emmanuel S. Antonarakis, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali, Neeraj Agarwal

    出版事項 2019
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors

    Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors 著者: Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, Julia A. Elvin, Jo‐Anne Vergilio, Jonathan Keith Killian, Nhu Ngo, Shakti Ramkissoon, Eric A. Severson, Amanda Hemmerich, Siraj M. Ali, Jon Chung, Prasanth Reddy, Vincent A. Miller, Alexa B. Schrock, Laurie M. Gay, Jeffrey S. Ross, Joseph M Jacob

    出版事項 2019
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer

    Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer 著者: Smruthy Sivakumar, Dexter X. Jin, Hanna Tukachinsky, Karthikeyan Murugesan, Kimberly McGregor, Natalie Danziger, Dean C. Pavlick, Ole Gjoerup, Jeffrey S. Ross, Robert J. Harmon, Jon Chung, Brennan Decker, Lucas Dennis, Garrett M. Frampton, Luciana Molinero, Steffi Oesterreich, Jeffrey M. Venstrom, Geoffrey R. Oxnard, Priti S. Hegde, Ethan Sokol

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus

    Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus 著者: Alexa B. Schrock, Dean C. Pavlick, Samuel J. Klempner, Jon Chung, Brady Forcier, Allison W. Welsh, Lauren Young, B Leyland-Jones, Rodolfo Bordoni, Richard D. Carvajal, Joseph Chao, Razelle Kurzrock, Jason K. Sicklick, Jeffrey S. Ross, Philip J. Stephens, Craig Devoe, Fadi Braiteh, Siraj M. Ali, Vincent A. Miller

    出版事項 2018
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study

    Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study 著者: Andrea Necchi, Andrea Anichini, Daniele Raggi, Alberto Briganti, Simona Massa, Roberta Lucianò, Maurizio Colecchia, Patrizia Giannatempo, Roberta Mortarini, Marco Bianchi, Elena Farè, Francesco Monopoli, Renzo Colombo, Andrea Gallina, Andrea Salonia, A. Messina, Siraj M. Ali, Russell W. Madison, Jeffrey S. Ross, Jon Chung, Roberto Salvioni, Luigi Mariani, Francesco Montorsi

    出版事項 2018
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer

    Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer 著者: Marco Bandini, Jeffrey S. Ross, Daniele Raggi, Andrea Gallina, Maurizio Colecchia, Roberta Lucianò, Patrizia Giannatempo, Elena Farè, Filippo Pederzoli, Marco Bianchi, Renzo Colombo, Giorgio Gandaglia, Nicola Fossati, Laura Marandino, Umberto Capitanio, Federico Dehò, Siraj M. Ali, Russell W. Madison, Jon Chung, Andrea Salonia, Alberto Briganti, Francesco Montorsi, Andrea Necchi

    出版事項 2020
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer

    Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer 著者: Pingping Mao, Ofir Cohen, Kailey J. Kowalski, Justin G. Kusiel, Jorge E. Buendia-Buendia, Michael S. Cuoco, Pedro Exman, Seth A. Wander, Adrienne G. Waks, Utthara Nayar, Jon Chung, Samuel S. Freeman, Orit Rozenblatt–Rosen, Vincent A. Miller, Federica Piccioni, David E. Root, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    RET rearrangements are actionable alterations in breast cancer

    RET rearrangements are actionable alterations in breast cancer 著者: Bhavna Paratala, Jon Chung, Casey Williams, Bahar Yilmazel, Whitney Petrosky, Kirstin Williams, Alexa B. Schrock, Laurie M. Gay, Ellen Lee, Sonia Dolfi, Kien Pham, Stephanie K. Lin, Ming Yao, Atul Kulkarni, Frances DiClemente, Chen Liu, Lorna Rodríguez-Rodríguez, Shridar Ganesan, Jeffrey S. Ross, Siraj M. Ali, Brian Leyland‐Jones, Kim M. Hirshfield

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: